INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/02/2026
Back to search
Official data from USPTO
EYBELIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
07/02/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/14/2017
Registration date
08/28/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2025
Last transaction
07/02/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
TANNER, MICHAEL R
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Santen Pharmaceutical Co., Ltd.
Representatives
John E. Lyhus FITCH, EVEN, TABIN & FLANNERY LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of cornea conjunctiva epithelium disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules for medicinescapsules sold empty for pharmaceuticals and drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cottoncotton for medical purposes and cotton sticks for medical purposesantiseptic cotton; adhesive plastersadhesive plasters for medical purposessticking plasters for medical purposes and medical and surgical plasters; bandages for dressings; liquid bandagesantiseptic liquid bandagesliquid bandage sprays and liquid bandages for skin wounds; breast-nursing pads; cotton sticks for medical purposes; incontinence diapers; diapers; diaper coversinserts specially adapted for cloth infant diapers made of microfiber and infant diaper covers of textile; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babiesinfant formula and meal replacement beverages for babies adapted for medical use; food for babies; dietary supplements for animals
Publications
History of USPTO decisions and trademark events.
33 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/13/2026
INPC
INVALIDATION PROCESSED
06/13/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/14/2025
C71T
CANCELLED SECTION 71
03/14/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/28/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/01/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/05/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/13/2018
FIMP
FINAL DISPOSITION PROCESSED
12/13/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/28/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
08/28/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/12/2018
PUBO
PUBLISHED FOR OPPOSITION
06/12/2018
GPNX
NOTIFICATION PROCESSED BY IB
06/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/23/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/23/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/23/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/07/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/25/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/16/2018
ALIE
ASSIGNED TO LIE
04/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2018
RFNP
REFUSAL PROCESSED BY IB
11/25/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/09/2017
RFRR
REFUSAL PROCESSED BY MPU
11/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
11/03/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/01/2017
CNRT
NON-FINAL ACTION WRITTEN
10/31/2017
DOCK
ASSIGNED TO EXAMINER
10/30/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/30/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/26/2017
Continuous trademark protection
Get notified about every new filing that threatens EYBELIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.